Tenon Medical, Inc. Revenues, Net of Interest Expense
Tenon Medical, Inc. (TNON) reported Revenues, Net of Interest Expense of $2.25 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Interest Expense
us-gaap:RevenuesNetOfInterestExpense · last filed 2024-03-29
- Tenon Medical, Inc. revenues, net of interest expense for fiscal 2023 was $2.25M.
| Period end | Revenues, Net of Interest Expense 12 month |
|---|---|
| 2023-12-31 | $2.25M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |